| Dr Nicholas John Dreyer, MD | |
|
8118 Good Luck Rd, Lanham, MD 20706-3574 | |
| (240) 686-2300 | |
| (240) 686-2330 |
| Full Name | Dr Nicholas John Dreyer |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 8118 Good Luck Rd, Lanham, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649767534 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MTL004631 (District Of Columbia) | Secondary |
| 207P00000X | Emergency Medicine | 0101275588 (Virginia) | Primary |
| Entity Name | Emergency Medicine Associates Pa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134117393 PECOS PAC ID: 8022914522 Enrollment ID: O20070919000389 |
News Archive
Just like physical health, it is important to check one's mental health amid the ongoing coronavirus pandemic. When countries announced lockdown orders, many people were confined to their homes, away from family and friends.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, today announced successful completion of the first phase I trial with its anti-inflammatory Spiegelmer® NOX-E36. This drug candidate will be developed for the treatment of complications of type 2 diabetes, preferentially diabetic nephropathy, but also others.
Eating steamed pears, having a soothing massage or bathing in a herbal mixture are just some of indigenous health practices used by older people to ward off or treat influenza, according to research published in the October issue of the Journal of Advanced Nursing.
Researchers at the University of Colorado Anschutz Medical Campus, along with seven other major institutions, have found that even mild postoperative pulmonary complications (PPCs) are significantly associated with increased death within the first week after surgery.
Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nicholas John Dreyer, MD 2150 Pennsylvania Ave Nw, Washington, DC 20037-3201 Ph: (202) 741-3000 | Dr Nicholas John Dreyer, MD 8118 Good Luck Rd, Lanham, MD 20706-3574 Ph: (240) 686-2300 |
News Archive
Just like physical health, it is important to check one's mental health amid the ongoing coronavirus pandemic. When countries announced lockdown orders, many people were confined to their homes, away from family and friends.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, today announced successful completion of the first phase I trial with its anti-inflammatory Spiegelmer® NOX-E36. This drug candidate will be developed for the treatment of complications of type 2 diabetes, preferentially diabetic nephropathy, but also others.
Eating steamed pears, having a soothing massage or bathing in a herbal mixture are just some of indigenous health practices used by older people to ward off or treat influenza, according to research published in the October issue of the Journal of Advanced Nursing.
Researchers at the University of Colorado Anschutz Medical Campus, along with seven other major institutions, have found that even mild postoperative pulmonary complications (PPCs) are significantly associated with increased death within the first week after surgery.
Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.
› Verified 5 days ago
Dr. Steven Scott Remsen Ii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 8118 Good Luck Road, Lanham, MD 20706 Phone: 301-552-8665 | |
Dr. Omolara Tolulope Oyedele, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8118 Good Luck Rd, Lanham, MD 20706 Phone: 202-741-8000 | |
Jessica Gabrielle Johnson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8118 Good Luck Rd, Lanham, MD 20706 Phone: 240-686-2300 | |
Dr. Moustafa S Shamma, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8118 Good Luck Rd, Lanham, MD 20706 Phone: 301-552-8665 | |
Dr. Michael J Buns, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 8118 Good Luck Rd, Lanham, MD 20706 Phone: 301-552-8665 | |
Dr. Royce Alan Burns, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8118 Good Luck Rd, Lanham, MD 20706 Phone: 301-498-2922 | |
Dane O'donnell, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 8118 Good Luck Rd, Lanham, MD 20706 Phone: 240-686-2300 Fax: 240-686-2330 |